193 related articles for article (PubMed ID: 21876729)
1. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
2. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
4. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation.
Ma J; Tang X; Wong P; Jacobs B; Borden EC; Bedogni B
J Biol Chem; 2014 Mar; 289(12):8442-9. PubMed ID: 24492617
[TBL] [Abstract][Full Text] [Related]
5. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
6. α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.
Li X; Meng X; Fan H; Wang Y; Jia Y; Jiao J; Ma X
Arch Dermatol Res; 2024 May; 316(6):269. PubMed ID: 38795191
[TBL] [Abstract][Full Text] [Related]
7. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
8. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin.
Lo Sardo V; Zuccato C; Gaudenzi G; Vitali B; Ramos C; Tartari M; Myre MA; Walker JA; Pistocchi A; Conti L; Valenza M; Drung B; Schmidt B; Gusella J; Zeitlin S; Cotelli F; Cattaneo E
Nat Neurosci; 2012 May; 15(5):713-21. PubMed ID: 22466506
[TBL] [Abstract][Full Text] [Related]
9. PAX2 may induce ADAM10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition.
Hou L; Du Y; Zhao C; Wu Y
Int Urol Nephrol; 2018 Sep; 50(9):1729-1741. PubMed ID: 30117015
[TBL] [Abstract][Full Text] [Related]
10. Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.
Qiu H; Tang X; Ma J; Shaverdashvili K; Zhang K; Bedogni B
Mol Cell Biol; 2015 Nov; 35(21):3622-32. PubMed ID: 26283728
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.
Fu L; Liu N; Han Y; Xie C; Li Q; Wang E
Tumour Biol; 2014 Sep; 35(9):9263-8. PubMed ID: 24935471
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
14. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
[TBL] [Abstract][Full Text] [Related]
16. High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.
Donizy P; Zietek M; Leskiewicz M; Halon A; Matkowski R
Anal Cell Pathol (Amst); 2015; 2015():975436. PubMed ID: 26266086
[TBL] [Abstract][Full Text] [Related]
17. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
Terzian T; Torchia EC; Dai D; Robinson SE; Murao K; Stiegmann RA; Gonzalez V; Boyle GM; Powell MB; Pollock PM; Lozano G; Robinson WA; Roop DR; Box NF
Pigment Cell Melanoma Res; 2010 Dec; 23(6):781-94. PubMed ID: 20849464
[TBL] [Abstract][Full Text] [Related]
18. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
[TBL] [Abstract][Full Text] [Related]
19. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
[TBL] [Abstract][Full Text] [Related]
20. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration.
Braig S; Wallner S; Junglas B; Fuchshofer R; Bosserhoff AK
Br J Cancer; 2011 Jul; 105(2):231-8. PubMed ID: 21673687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
